SCHEMBL2811974

SCHEMBL2811974

Clc1cncc(Cl)c1N1CCN(c2nc3c4c(n[nH]c4n2)CCN3Cc2ccccc2)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.36
HCAR2 Q8TDS4 1/20 0.36
LMNA P02545 3/20 0.36
HTT P42858 2/20 0.36
NPSR1 Q6W5P4 3/20 0.35
ALDH1A1 P00352 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
HTR2A P28223 1/20 0.35
HTR2C P28335 1/20 0.35
KDM4E B2RXH2 2/20 0.35
MAPT P10636 1/20 0.35
MAPK1 P28482 1/20 0.35
CASP1 P29466 1/20 0.34
CASP5 P51878 1/20 0.34
CCNC P24863 1/20 0.34
CDK8 P49336 1/20 0.34
ACHE P22303 2/20 0.33
ADRB2 P07550 1/20 0.33
DRD2 P14416 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2812360 0.86 DRD4 (0.43) GAALMNAHTTNPSR1ALDH1A1
SCHEMBL2809499 0.85 HTR6 (0.46) GAAHTTALDH1A1HTR2AHTR2C
SCHEMBL2809641 0.85 ALDH1A1 (0.44) GAAALDH1A1KDM4EACHEDRD2
SCHEMBL2812038 0.85 BRS3 (0.44) GAAL3MBTL1CASP1CASP5BRS3
SCHEMBL2808212 0.85 SIGMAR1 (0.47) GAAHTTNPSR1ALDH1A1SMN1; SMN2
SCHEMBL2810794 0.84 GAA (0.45) GAALMNAHTTNPSR1ALDH1A1
SCHEMBL2808367 0.84 CASP1 (0.48) GAALMNAHTTNPSR1ALDH1A1
SCHEMBL2809831 0.83 DRD4 (0.41) GAALMNAHTTALDH1A1L3MBTL1
SCHEMBL2810536 0.82 HTR2A (0.48) GAALMNAHTTALDH1A1SMN1; SMN2
SCHEMBL2809602 0.82 LMNA (0.43) LMNAHTTALDH1A1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS DPYD, TYMP, TP53 GAA 1908/4885HCAR2 2664/4885LMNA 2815/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.